Dilazep
![]() | |
Systematic (IUPAC) name | |
---|---|
3-(4-{3-[(3,4,5-Trimethoxyphenyl)carbonyloxy]propyl}-1,4-diazepan-1-yl)propyl 3,4,5-trimethoxybenzoate | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
ATC code | C01DX10 (WHO) |
PubChem | CID 3074 |
IUPHAR/BPS | 4717 |
ChemSpider |
2965 ![]() |
UNII |
F8KLC2BD5Z ![]() |
KEGG |
D07843 ![]() |
ChEMBL |
CHEMBL126075 ![]() |
Chemical data | |
Formula | C31H44N2O10 |
Molar mass | 604.69 g/mol |
| |
| |
(verify) |
Dilazep is a vasodilator that acts as an adenosine reuptake inhibitor.[1]
See also
- Hexobendine, a drug with similar chemical structure
References
- ↑ Hiroshi Deguchi, Hiroyuki Takeya, Hideo Wada, Esteban C. Gabazza, Nobuyuki Hayashi, Hajime Urano, and Koji Suzuki (September 15, 1997). "Dilazep, an Antiplatelet Agent, Inhibits Tissue Factor Expression in Endothelial Cells and Monocytes". Blood 90: 2345–2356.
|
|
This article is issued from Wikipedia - version of the Tuesday, May 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.